Aligos Therapeutics Investors

18 investors on Angel Roster list Aligos Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Taiwan.

Investors are matched on the company name in their portfolio, so companies that share the name Aligos Therapeutics can appear together.

Investors listed
18
With verified email
33%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 18 Aligos Therapeutics investors

The most complete profiles first. Showing 18 of 18.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Brian AtwoodVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsCybersecurityWomen Founded

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Alexander MaywegVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Carlo Rizzuto

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more

    Contact details available

  • Charles Warden

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Ross Jaffe

    Venture Capital, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Beckie Robertson

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Bill Link

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Don Milder

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Paul Grayson

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

Frequently asked questions

How many Aligos Therapeutics investors are on Angel Roster?

Angel Roster lists 18 Aligos Therapeutics investors. 6 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (12) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Aligos Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (4) and Series B (4).

Where are Aligos Therapeutics investors based?

Most are based in the United States (14), China (2) and Taiwan (1).

Which companies have Aligos Therapeutics investors backed?

The most-backed portfolio companies among them are Passage Bio (18), Crinetics Pharmaceuticals (17), Akero Therapeutics (10), Vividion Therapeutics (10) and Black Diamond Therapeutics (10).

How do I contact Aligos Therapeutics investors?

Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.